文献速递甲状腺疾病

小低危甲状腺乳头状癌选择手术或主动监测后的决策后悔:一项前瞻性队列研究

Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
PubMed 文献 · Thyroid · 2024-04-08

该前瞻性观察队列纳入加拿大小于2厘米低危甲状腺乳头状癌患者,让其选择主动监测(AS)或手术,决策一年后填写问卷。意向性分析显示AS组与手术组平均决策后悔量表总分无显著差异,但初始选AS后转为手术者后悔评分显著高于继续AS者。

要点

  • 问卷应答率95.5%(191/200),初始选择AS者79.1%(151/191),手术者20.9%(40/191)。
  • AS组平均决策后悔22.4(SD 13.9)与手术组20.9(SD 12.2)粗分析p=0.730、调整后p=0.29,无显著差异。
  • 初始选AS后转为手术者调整后决策后悔显著高于继续AS者(β=10.1,CI 1.3-18.9,p=0.02)。

核心结论

  • 在小低危甲状腺乳头状癌患者中,初始疾病管理选择相关的一年平均决策后悔水平相对较低,选择AS或手术的应答者之间无显著差异。

研究设计与样本

  • 前瞻性观察队列研究,纳入加拿大小于2厘米低危甲状腺乳头状癌患者,提供主动监测(AS)或手术选择(Clinicaltrials.gov NCT03271892)。
  • 参与者在治疗决策一年后完成问卷,主要采用意向性分析比较AS与手术组平均决策后悔量表总分。
  • 二次分析按治疗状态检查一年决策后悔评分,并分析生活质量、情绪、疾病进展恐惧和身体意象等次要结局。
  • 线性回归分析调整了年龄、性别和随访时长。

主要发现

  • 问卷总应答率95.5%(191/200),应答者初始选择AS 79.1%(151/191)、手术20.9%(40/191)。
  • 平均年龄53岁(SD 15岁),女性77%(147/191)。
  • AS组中7.3%(11/151)在完成问卷前转为确定性治疗,其中2例因疾病进展。
  • 选择AS者平均决策后悔22.4(SD 13.9)与选择手术者20.9(SD 12.2)在粗分析(p=0.730)或调整分析(p=0.29)中均无显著差异。
  • 初始选择AS后转为手术者调整后决策后悔显著高于继续AS者(β系数10.1[CI 1.3-18.9],p=0.02)。

关键数值与推荐

  • 二次调整分析中,选择手术的应答者报告癌症或其治疗相关症状干扰生活的程度大于选择AS者(p=0.02)。
  • 抑郁、焦虑、疾病进展恐惧或整体身体意象感知水平在组间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: It is important to understand cancer survivors' perceptions about their treatment decisions and quality of life. Methods: We performed a prospective observational cohort study of Canadian patients with small (<2 cm) low-risk papillary thyroid cancer (PTC) who were offered the choice of active surveillance (AS) or surgery (Clinicaltrials.gov NCT03271892). Participants completed a questionnaire one year after their treatment decision. The primary intention-to-treat analysis compared the mean decision regret scale total score between patients who chose AS or surgery. A secondary analysis examined one-year decision regret score according to treatment status. Secondary outcomes included quality of life, mood, fear of disease progression, and body image perception. We adjusted for age, sex, and follow-up duration in linear regression analyses. Results: The overall questionnaire response rate was 95.5% (191/200). The initial treatment choices of respondents were AS 79.1% (151/191) and surgery 20.9% (40/191). The mean age was 53 years (standard deviation [SD] 15 years) and 77% (147/191) were females. In the AS group, 7.3% (11/151) of patients crossed over to definitive treatment (two for disease progression) before the time of questionnaire completion. The mean level of decision regret did not differ significantly between patients who chose AS (mean 22.4, SD 13.9) or surgery (mean 20.9, SD 12.2) in crude (p = 0.730) or adjusted (p = 0.29) analyses. However, the adjusted level of decision regret was significantly higher in patients who initially chose AS and crossed over to surgery (beta coefficient 10.1 [confidence interval; CI 1.3-18.9], p = 0.02), compared with those remaining under AS. In secondary adjusted analyses, respondents who chose surgery reported that symptoms related to their cancer or its treatment interfered with life to a greater extent than those who chose AS (p = 0.02), but there were no significant group differences in the levels of depression, anxiety, fear of disease progression, or overall body image perception. Conclusions: In this study of patients with small, low-risk PTC, the mean level of decision regret pertaining to the initial disease management choice was relatively low after one year and it did not differ significantly for respondents who chose AS or surgery.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Sawka AM, Ghai S, Rotstein L, et al. Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study. Thyroid. 2024. PMID: 38481111. doi:10.1089/thy.2023.0634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。